234 related articles for article (PubMed ID: 16791660)
21. Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy.
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2005 Dec; 26(6):575-616. PubMed ID: 16388429
[TBL] [Abstract][Full Text] [Related]
22. [Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
Roger PM; Risso K; Hyvernat H; Landraud L; Vassallo M; Dellamonica J; de Salvador F; Cua E; Bernardin G
Med Mal Infect; 2010 Jun; 40(6):347-51. PubMed ID: 20172672
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
Lismond A; Carbonnelle S; Verhaegen J; Schatt P; De Bel A; Jordens P; Jacobs F; Dediste A; Verschuren F; Huang TD; Tulkens PM; Glupczynski Y; Van Bambeke F
Int J Antimicrob Agents; 2012 Mar; 39(3):208-16. PubMed ID: 22245497
[TBL] [Abstract][Full Text] [Related]
24. Doxycycline for treatment of community-acquired pneumonia.
Johnson JR
Clin Infect Dis; 2002 Sep; 35(5):632; author reply 632-3. PubMed ID: 12173142
[No Abstract] [Full Text] [Related]
25. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
Ioachimescu OC; Ioachimescu AG; Iannini PB
Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
[TBL] [Abstract][Full Text] [Related]
26. Severe pneumococcal pneumonia: new strategies for management.
Chiou CC; Yu VL
Curr Opin Crit Care; 2006 Oct; 12(5):470-6. PubMed ID: 16943728
[TBL] [Abstract][Full Text] [Related]
27. Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia.
Georges H; Leroy O; Vandenbussche C; Guery B; Alfandari S; Tronchon L; Beaucaire G
Intensive Care Med; 1999 Feb; 25(2):198-206. PubMed ID: 10193548
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of β-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia.
Yoshioka D; Kajiwara C; Ishii Y; Umeki K; Hiramatsu K; Kadota J; Tateda K
Antimicrob Agents Chemother; 2016 Oct; 60(10):6146-54. PubMed ID: 27480866
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for drug-resistant Streptococcus pneumoniae and antibiotic prescribing practices in outpatient community-acquired pneumonia.
Jenkins TC; Sakai J; Knepper BC; Swartwood CJ; Haukoos JS; Long JA; Price CS; Burman WJ
Acad Emerg Med; 2012 Jun; 19(6):703-6. PubMed ID: 22632455
[TBL] [Abstract][Full Text] [Related]
30. [Community acquired pneumococcal pneumonia in hospitalized adult patients].
Díaz A; Torres C; Flores LJ; García P; Saldías F
Rev Med Chil; 2003 May; 131(5):505-14. PubMed ID: 12879811
[TBL] [Abstract][Full Text] [Related]
31. [New quinolones for the treatment of community-acquired pneumonia--contra].
Egger M
Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
[No Abstract] [Full Text] [Related]
32. In vivo veritas: in vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure.
Jacobs MR
Clin Infect Dis; 2002 Sep; 35(5):565-9. PubMed ID: 12173130
[No Abstract] [Full Text] [Related]
33. Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae.
Plouffe JF; Martin DR
Infect Dis Clin North Am; 2004 Dec; 18(4):963-74; x-xi. PubMed ID: 15555834
[TBL] [Abstract][Full Text] [Related]
34. Community-acquired pneumonia: new management strategies for evolving pathogens and antimicrobial susceptibilities.
Klugman KP; Low DE; Metlay J; Pechere JC; Weiss K
Int J Antimicrob Agents; 2004 Nov; 24(5):411-22. PubMed ID: 15519470
[TBL] [Abstract][Full Text] [Related]
35. What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia?
File TM; Mandell LA
Clin Infect Dis; 2003 Feb; 36(4):396-8. PubMed ID: 12567295
[No Abstract] [Full Text] [Related]
36. Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000-2013).
Gattarello S; Borgatta B; Solé-Violán J; Vallés J; Vidaur L; Zaragoza R; Torres A; Rello J;
Chest; 2014 Jul; 146(1):22-31. PubMed ID: 24371840
[TBL] [Abstract][Full Text] [Related]
37. Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
Lee WK; Young BW
J Antimicrob Chemother; 2005 Sep; 56(3):603-5. PubMed ID: 16040621
[No Abstract] [Full Text] [Related]
38. Penicillin resistance in pneumococcal pneumonia. Antibiotics with low resistance potential are effective and pose less risk.
Cunha BA
Postgrad Med; 2003 Jan; 113(1):42-4, 47-8, 52-4. PubMed ID: 12545592
[TBL] [Abstract][Full Text] [Related]
39. Severe pneumonia and a second antibiotic.
Macfarlane J
Lancet; 2002 Apr; 359(9313):1170-2. PubMed ID: 11955532
[No Abstract] [Full Text] [Related]
40. [Guideline 'Diagnosis and treatment of community-acquired pneumonia' from the Dutch Thoracic Society].
Aleva RM; Boersma WG;
Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2501-7. PubMed ID: 16304887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
